Re: your statement “Some never-CVS posters here have posted that...

First 13 Last

Share
Profile

Follow
MeToo

3,857 Posts.

79

24/06/18

19:22

Post #: 33914274
Share

Originally posted by rdncoic ↑

Some never-CVS posters here have posted that they have difficulties in understanding price sensitive documents posted here on the CVS thread. I am a real nice person and so I will help them to understand just what the document is possibly announcing. The information posted below may or not mean that positive results have been assessed in reference to initial drilling results but prior to commencement of trading on Tuesday 26 June 2018 everyone will know just why CVS requested a trading halt. In order to quell insider trading or whatever, a trading stop is now in effect.

The trading stop also means that if there is a spike in SP, it will be too late to buy in on the low if you have not done so already. You will have to buy in on the high. But not to worry because I have a lot of shares of CVS to sell you in the event of a SP increase or spike. I will be glad to help you all out with expensive shares of CVS. I always want to help out the less fortunate. If no "Ball Buster News" is posted, we can all go back to sleep until the full report is released...............................

In accordance with ASX Listing Rule 17.1, Cervantes Corporation Ltd (ASX:CVS) (“Cervantes or the Company”) requests a trading halt over the Company’s securities. The Company intends to make an announcement pending the assessment of initial drilling results.

The Company requests the trading halt be granted until the Company finalises a release in relation to the drilling results, which is expected to be released prior to the commencement of trading on Tuesday 26 June 2018.

Expand

Re: your statement “Some never-CVS posters here have posted that they have difficulties in understanding price sensitive documents posted here on the CVS thread.”

Now yet again, rdncoic, you are making things up, no one else has said that!

CVS Price at posting: 0.7¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

There are more pages in this discussion • 5 more messages in this thread...

First 13 Last

Add CVS (ASX) to my watchlist

Re: your statement “Some never-CVS posters here have posted that...

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia